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XDiscussion
Dr Abbas Ardehali (Los Angeles, Calif). This is a relevant and
important study in the field of thoracic transplantation. It tries to
address the issue of why otherwise healthy donors have poor LV
function when the heart is offered for transplantation, and in
a broader sense it tries to address the issue of the donor shortage.
To put the issue of donor shortage in perspective, let me share
with you some numbers. There were 8100 consented kidney do-
nors last year in the United States, yet only 2300 of them were
heart donors, so approximately 70% of these consented donors
could not be heart donors. Although there are many explanations
for such discrepancies, such as distance, poor size, match, or donor
heart quality (eg, LV hypertrophy or coronary artery disease), an
important cohort is a group of donors who are otherwise healthy
and have no symptoms, but their heart is just not good. This study
tries to address this cohort and suggest that if you attach an extra-
corporeal circuit to them and remove these ‘‘evil humors,’’ the
heart is somehow going to turn out to be good and usable. This
is a relevant observation in that it can open up a new cohort of po-
tential heart donors.
I want to ask you 3 questions. The first refers to a mechanistic
explanation of the beneficial effects of HA. As you mentioned, the
filter that you used removes all molecules between 10 and 40 kDa,
but in addition to cytokines there aremany other circulating peptides
and nonprotein molecules that are removed or altered via exposure
with this membrane. The fact that you just lowered the level of TNF
and IL-6 does not necessarily establish a cause-and-effect relation-
ship but just anassociation.Canyouexpandon themechanismof the
beneficial effects of HA on the donor heart function?
Dr Rabkin. I could not agree with you more. This filter is not
specific to cytokines. In fact, the pores are sized between 20 and
50 kDa, but there is actually no way to prevent molecules even
smaller than 20 kDa from getting trapped into these pores, so
they are not specific to the inflammatory cytokines, and to try to
draw a direct link between the observed changes in function and
the changes in the cytokines that we noted would be inappropriate.
I think we can only say that the overall intervention of placing the
animals on the circuit is having some beneficial effect. This study
was not designed to investigate the mechanism, but we made some
attempts in the study to do various regression analyses to try to
draw a link between specific cytokines and specific parametersThe Journal of Thoracic and Caof ventricular function and found only a loose correlation. I think
the highest correlation coefficient was approximately 0.3, suggest-
ing that 30% of the observed effect could be attributed to a partic-
ular cytokine. There is a lot going on here in brain death
physiology other than the surge in cytokines. Certainly those
things are contributing to the changes in function that we have
seen, but to summarize, to directly address your question, I agree,
we cannot attribute the changes here to changes in the cytokine
concentration themselves.
Dr Ardehali. The second question is a practical one. As you
know, if you plan to do anything to a donor in any hospital in
the United States, you have to get the approval from up to 9 other
teams procuring other organs in addition to the organ procurement
agency. What do we know about the effect of HA on kidneys,
livers, lungs, cornea, and skin? The other relevant question is
can it be done in a small community hospital? And what are
some of the downsides of this technology?
Dr Rabkin. Those are excellent points. In terms of the first
question, the effects on other organ function, we looked at some
crude measurements of hepatic and renal and pulmonary function.
We did not find any changes in hepatic enzymes in any of the
groups, neither did we find any changes in the arterial oxygen ten-
sion of the animals, which was completely normal for all points af-
ter establishment of brain death. In terms of the renal function, we
did find that in the 2 brain death groups there was an increase in
creatinine over time, and that difference was statistically signifi-
cant for the brain death group, but we were skeptical there would
be such a significant change in creatinine in such a short time
frame. Also, in terms of the (RIFLE) criteria, which is a doubling
of the baseline creatinine, I think 3 and 4 animals were in the brain
death + HA group and the brain death alone group, respectively.
Again, wewere skeptical of that because in the absence of prerenal
azotemia we would not expect to see such a quick increase in cre-
atinine. Finally, we looked at NGAL, which is an early and sensi-
tive biomarker of renal injury, and we were able to show
a significant increase in NGAL in the brain death group, which
was not present in the brain death + HA group. However, just as
I was writing the article I thought to check the size of the NGAL
molecule, and it falls squarely in the range that the filter is picking
up, so I think you could attribute those differences to the fact that
the NGAL was getting caught up in the filter in the experimental
group. Therefore, we were not able to show any reliable effects
of this technology on other organ function.
In terms of the practicality of doing this and getting agreement
from the other teams, logistically it presents a lot of problems.
However, it is doable. John Kellum and colleagues at Pittsburgh
published an article that demonstrated the feasibility of using
this technology in a clinically relevant procurement scenario;
they placed brain-dead patients ineligible for organ transplant
for whatever reason on the HA circuit and showed that they could
bring down the cytokine concentrations and that it was possible to
do this. The equipment required is available in a community
hospital; I think it is nothing more than you would need for putting
patients on dialysis.
The only other comment I would make is that we set out to de-
velop a method of trying to rehabilitate hearts from the pathophys-
iology of brain death, and that is not really what we finally did. We
seemed to arrest the deterioration in function; however, we neverrdiovascular Surgery c Volume 145, Number 1 223
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Xreally showed an improvement, and this is assuming mobilization
of the required resources within 3 hours of establishing brain
death, which is probably not a realistic time frame in the commu-
nity to try to get a brain-dead patient into the hospital.224 The Journal of Thoracic and Cardiovascular SurgModerator. David, could you wrap it up please.
Dr Rabkin. Of course, so I am not sure if this is the best
application of this technology, but I think it is interesting enough
to pursue and might be applicable in other contexts.ery c January 2013
